Gonadotropin treatment augments postnatal oogenesis and primordial follicle assembly in adult mouse ovaries? by Deepa Bhartiya et al.
Bhartiya et al. Journal of Ovarian Research 2012, 5:32
http://www.ovarianresearch.com/content/5/1/32RESEARCH Open AccessGonadotropin treatment augments postnatal
oogenesis and primordial follicle assembly in
adult mouse ovaries?
Deepa Bhartiya*, Kalpana Sriraman, Pranesh Gunjal and Harshada ModakAbstract
Background: Follicle stimulating hormone (FSH) exerts action on both germline and somatic compartment in both
ovary and testis although FSH receptors (FSHR) are localized only on the somatic cells namely granulosa cells of
growing follicles and Sertoli cells in the seminiferous tubules. High levels of FSH in females are associated with poor
ovarian reserve, ovarian hyper stimulation syndrome etc. and at the same time FSH acts as a survival factor during
in vitro organotypic culture of ovarian cortical strips. Thus a further understanding of FSH action on the ovary is
essential. We have earlier reported presence of pluripotent very small embryonic-like stem cells (VSELs express
Oct-4A in addition to other pluripotent markers) and their immediate descendants ‘progenitors’ ovarian germ stem
cells (OGSCs express Oct-4B in addition to other germ cell markers) in ovarian surface epithelium (OSE) in various
mammalian species including mice, rabbit, monkey, sheep and human. Present study was undertaken to investigate
the effect of pregnant mare serum gonadotropin (PMSG) on adult mice ovaries with a focus on VSELs, OGSCs,
postnatal oogenesis and primordial follicle assembly.
Methods: Ovaries were collected from adult mice during different stages of estrus cycle and after 2 and 7 days of
PMSG (5 IU) treatment to study histo-architecture and expression for FSHR, pluripotent stem cells , meiosis and
germ cell specific markers.
Results: PMSG treatment resulted in increased FSHR and proliferation as indicated by increased FSHR and PCNA
immunostaining in OSE and oocytes of primordial follicles (PF) besides the granulosa cells of large antral follicles.
Small 1–2 regions of multilayered OSE invariably associated with a cohort of PF during estrus stage in control ovary
were increased to 5–8 regions after PMSG treatment. This was associated with an increase in pluripotent transcripts
(Oct-4A, Nanog), meiosis (Scp-3) and germ cells (Oct-4B, Mvh) specific markers. MVH showed positive immuno
staining on germ cell nest-like clusters and at places primordial follicles appeared connected through oocytes.
Conclusions: The results of the present study show that gonadotropin (PMSG) treatment to adult mouse leads to
increased pluripotent stem cell activity in the ovaries, associated with increased meiosis, appearance of several
cohorts of PF and their assembly in close proximity of OSE. This was found associated with the presence of germ
cell nests and cytoplasmic continuity of oocytes in PF. We have earlier reported that pluripotent ovarian stem cells
in the adult mammalian ovary are the VSELs which give rise to slightly differentiated OGSCs. Thus we propose that
gonadotropin through its action on pluripotent VSELs augments neo-oogenesis and PF assembly in adult mouse
ovaries.
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Follicle-stimulating hormone (FSH) is a pleiotropic hor-
mone produced by the pituitary and exerts its action on
the ovary by inducing proliferation, differentiation and
steroidogenesis in the granulosa cells of growing pre-
ovulatory follicles. The initial development of primordial
follicles (PF) is believed to be FSH independent [1].
However, several reports have shown that appreciable
amount of FSH is present in serum of perinatal mice [2],
rats [3], hamsters [4,5] and humans [6]. Elevated FSH
levels are found to be associated with altered ovarian
function including diminished ovarian reserve, pre-mature
ovarian failure, infertility, ovarian hyper-stimulation syn-
drome, poor quality of eggs, menopause [7,8] and also a
huge body of literature exists suggesting an association
with ovarian cancers [9,10]. At the same time, FSH
acts as a survival factor during PF transition to primary/
secondary follicles in serum-free ovarian cortical tissue
culture [11]. Studies in hamster using anti-FSH anti-
bodies have shown that FSH action is also required for
formation of primordial follicles [12]. They showed that
a single dose of FSH specific polyclonal antibody during
gestational period could significantly affect the number
of primordial follicles after birth. Demeestere et al. [13]
recently concluded that FSH possibly coordinates devel-
opment of both germline and somatic compartments of
the mouse follicle. FSH is also known to exert similar
dual effect on both the germline and somatic cells in
the testis. Rao et al. [14] reported that by blocking the
action of FSH using phage-expressed extracellular do-
main of FSHR results in azoospermia after 100 days in
non-human primates although FSHR are localized only
on the surface of Sertoli cells. It remains rather unclear
as to how FSH can exert action on both somatic and
germline compartment of the ovarian follicles and in the
testis, although FSHR are expressed only on the somatic
cells namely granulosa cells of developing follicles and
on Sertoli cells in the testis. Although indirect action on
germ cells through paracrine-autocrine interactions is
suggested, mechanism underlying FSH action on the
mammalian gonads needs further investigation.
Several published reports using ovarian tissue or
immortalized ovarian epithelial cell lines show that be-
sides granulosa cells, FSH receptors (FSHR) are also
localized on the normal ovary surface epithelium [15-17]
and in ovarian tumor surface epithelium [9,18-26].
Oocytes have also been reported to express FSHR. FSHR
mRNA was detected in the oocytes and cleavage stage
mouse embryos [27]. FSHR is reported to be 20 fold
higher in the human oocytes compared to granulosa
cells [28]. Various techniques like in situ hybridization,
RT-PCR, Q- PCR and immunolocalization studies have
been used to demonstrate FSHR in the OSE of mice,
rats, cows and humans [9,15,17,19]. Few studies havealso shown that OSE undergoes rapid proliferation in re-
sponse to PMSG [29-31], based on BrdU uptake or
PCNA staining. All these studies suggest that FSH acting
through FSHR localized in OSE may have an important
role in ovarian biology. It is imperative to mention here that
these published reports assume greater significance, since
recently it has been reported by several groups [32-38]
that the OSE also houses ovarian stem cells which may
contribute to postnatal oogenesis. Hence, PMSG induced
FSH action in adult mouse can serve as a good model to
understand the probable mechanism of FSH action on
stem cells as well as in new follicular development. Our
group earlier reported that OSE in mice, rabbits, sheep,
monkeys and women harbors two distinct stem cell popu-
lations that include the pluripotent very small embryonic-
like stem cells (VSELs) and their immediate descendants
‘progenitors’ ovarian germ stem cells (OGSCs) [32,39]. We
have further implicated these stem cells in postnatal
oogenesis and proposed a working model for the same [39].
The concept of postnatal oogenesis in mammalian
ovary is a highly debated area of research and several
investigators have contributed both in favor [36,39-42]
and against [43,44] in the recent past. Tilly’s and co-
workers [36] were the initial group to generate evidence
against the concept of fixed number of eggs at the time
of birth and their recent paper [45] provides unequivocal
evidence to support the presence of mitotically active
germ cells that can generate oocytes both in vitro and
in vivo. The existing controversy regarding existence of
stem cells in adult mammalian ovary appears to be more
of technical nature [46] or markers [47] used to study the
stem cells rather than absence of stem cells itself. Re-
cently, Gamwell and co-workers [48] recently reported a
side population in mouse OSE that excludes Hoechst dye
and express Sca-1 along with Nanog and Kit.
The present study was undertaken to study the effect of
PMSG on mouse ovary with a focus on stem cells located
in the OSE. Besides normal estrus cycle, ovaries were stud-
ied 2 and 7 days after PMSG treatment. Normally 2 days
are required to stimulate maturation of follicles in a stand-
ard super-ovulation protocol using PMSG and hence 2
days was chosen to study the standard effect. A longer
time period of 7 days was chosen to understand delayed
effect and to get insights into the effect of FSH on ovarian
stem cells. What is the effect of FSH when the ovary is
super-ovulated during assisted reproduction, how does
FSH treatment affect the OSE, does it have any effect on
the stem cells and whether postnatal oogenesis and PF as-
sembly is affected by FSH treatment are open questions
that remain to be answered.
Materials & methods
The study was approved by Institute Animal Ethics
Committee and was carried out using in-house bred








Estrous 2 4 4 -
Pro-estrus 1 2 2 -
Di-estrus 10* 20 8 12
2D PMSG 12* 24 14 10
7D PMSG 12* 24 14 10
* Total number of animals used in 4 different experiments.
§ Whole ovary was sectioned and every third slide was used for H&E staining.
The rest of the slides were used for IHC.
#Two ovaries from two animals were pooled to make one sample for RNA
isolation. Only samples showing good A260/A280 ratio after RNA isolation were
used for RT/Q-PCR study.
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stitute. Mice were housed in a temperature and humidity
controlled room on a 12hr light/12hr darkness cycle
with free access to food and water.
Different stages of estrus cycle were monitored by
daily examination of vaginal smears of one month old
female mice. Briefly, the vaginal swabs were prepared
using sterile PBS dipped cotton swabs, fixed in 100%
methanol, stained with Giemsa and observed under a
90i microscope (Nikon, Tokyo, Japan). Ovaries were
collected during different stages of estrus cycle namely
estrus, proestrus and diestrus (DE). Ovaries were also
collected from mice treated with subcutaneous injection
of 5IU PMSG (National Hormone & Peptide Program,
Harbor-UCLA Medical Center, California, USA) after 2
days (2D) and 7 days (7D) of treatment. All PMSG
injections were done in normal cycling mice at DE
stage and mice at DE stage were used as controls for
the experiments. The experimental design and number
of animals used in the present study are shown in
Table 1. The collected ovaries were fixed in 4% forma-
lin for histology and immunolocalization studies and
also in TRIZOL for RNA extraction to analyze various
gene transcripts of interest by RT-PCR and Q-PCR.
The ovaries were carefully dissected from all the adher-
ing extraneous tissue under a stereomicroscope with
the help of a micro scissor prior to freezing for RNA.Table 2 Details of antibodies used for immunolocalization stu
Antibody Marker Sourc
FSHR Polyclonal FSHR: membrane bound receptor of FSH Gift
PCNA
Monoclonal
PCNA: nuclear protein that functions during
DNA replication
Sigma
OCT-4 Polyclonal OCT-4 isoforms: OCT-4A is a nuclear transcription
factor and OCT-4B is cytoplasmic
Abcam
SCP3 Polyclonal SCP3: a nuclear protein required for homologous
recombination during meiosis I
Abcam
VASA Polyclonal MVH: germ cell specific cytoplasmic protein
expressed from primordial germ cell stage
R&D
SystemHistological studies
Formalin fixed ovaries were processed and embedded in
paraffin using standard protocols. 5μm thick sections of
the embedded ovaries were prepared and stained with
Hematoxylin and Eosin for studying the histo- architec-
ture during different phases of estrus cycle and after
treatment with PMSG. The representative areas were
photographed using 90i microscope and data recorded.
Immunohistochemistry (IHC)
Immunolocalization studies were carried out for various
antigens listed in Table 2. Briefly, the paraffin sections
were deparaffinized, hydrated and antigen retrieval was
performed with boiling SSC buffer of pH 6 in microwave
for 5 min (cytoplasmic antigens) or 15 min (nuclear
antigens). After cooling, the slides were washed with Tris
buffer saline (TBS) for 5 min and processed further for
blocking with 10% NGS and 1% BSA in TBS. After re-
moving excess blocking reagent, the slides were incu-
bated with primary antibody diluted with 1% BSA in
TBS for two hrs at room temperature. For negative
control, the antibody was omitted and sections were
incubated with 1% BSA in TBS. In case of FSHR detec-
tion alone, negative control included the pre-immune
sera from rabbit in which the primary antibody was
raised. The detection was done using anti mouse Vecta
ABC kit (Vector Laboratories, USA) according to man-
ufacturer’s instructions. Final color development was
done using DAB (Biogenex, USA). After counterstaining
with Haematoxylin, the slides were observed under 90i
microscope. Representative areas were photographed.
RNA isolation and cDNA synthesis
Total RNA was extracted by standard protocol using
Trizol (Invitrogen, Carlsbad- CA, USA) and treated with
DNase I (Amersham Biosciences, Piscataway, NJ) to re-
move any genomic DNA present. First-strand cDNA
was synthesized using the iScript cDNA synthesis kit
(Bio-Rad, USA) according to the manufacturer’s instruc-
tions. Briefly, 1μg of total RNA was incubated with 5x
reaction mix and reverse transcriptase mix. The reaction
was carried out in G-STORM thermocycler (Genedies
e Dilution Reason to conduct IHC Ref
1:100 To study cells responsive to PMSG [49]
1:5000 To study proliferating cells [50]
1:100 To study pluripotent and progenitor
stem cells
[32]
1:500 To study presence of cells undergoing
meiosis
[36]
1:500 To study early germ cells and oocytes [51,52]
Table 3 Primers used for RT- PCR and Q-PCR
Gene Primer Annealing
Temp (° C)
Fshr F: TGGAGGCGGCAAACCTCTGAAC 65
R: TCTGGCTTTGGCGAGCAGGTC
Oct-4A F: CCATGTCCGCCCGCATACGA 61
R: GGGCTTTCATGTCCTGGGACTCCT
Total F: CCTGGGCGTTCTCTTTGGAAAGGTG 68
Oct-4 R: GCCTGCACCAGGGTCTCCGA
Nanog [34] F: CAGGAGTTTGAGGGTAGCTC 61
R: CGGTTCATCATGGTACAGTC
Stella F: ACGCTTTGGATGATACAGACGTCC 67
R: GCGCTTTGAACTTCCCTCCGGA
Fragilis F: GGGGTGACTGAGCTGGGGGAA 65
R: TGTCCCTAGACTTCACAGAGTAGGC




Mvh F: AGTGGAAGTGGTCGAGGTGGT 61
R: TGCCGGTGGTGCATCATGTCC
Scp3 F: TGTTGCAGCAGTGGGAACTGGAT 68
R: CCATCTCTTGCTGCTGAGTTTCCA
Dmc-1 F: TGGGGAATTGGCTGAACGCC 68
R: CAGGCATCTCGGGGCTGTCATAA




Gapdh [34] F: GTCCCGTAGACAAAATGGTGA 58
R: TGCATTGCTGACAATCTTGAG
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incubated at 25°C for 5 min, then at 42°C for 30 min
and finally at 85°C for 5 min.
Both RT-PCR and Q-PCR were employed to study
gene transcripts expression for the following markers:
pluripotent stem cell specific markers (Oct-4A: isoform
A of octamer binding transcription factor 4 [53,54] and
Nanog: homeobox transcription factor also expressed in
primordial germ cells [55]); early primordial germ cell
markers (Oct-4, represented here as total Oct-4 as it
includes all isoforms of Oct-4 including isoform B
expressed in cytoplasm of OGSCs [32]), Stella [56],
Fragilis [57], Mvh mouse vasa homolog, plays a role in
oogenesis, germ cell and follicle development); oocyte
specific markers (Nobox newborn ovary homeobox-
encoding gene is essential for folliculogenesis [58],
HoxA10 homoeobox gene restricted to primordial and
early primary follicular oocytes [58]); pre-meiotic marker
(Stra8 stimulated by retinoic acid gene 8 essential for
meiotic initiation [59]); meiotic marker (Scp3 synapto-
nemal complex protein 3 and Dmc1 required for,
meiosis specific homologous recombination) and PMSG
action mediator (Fshr). Each sample was obtained by
pooling ovaries from two different animals.
Reverse –transcription PCR
RT-PCR was carried out to study the expression of
meiotic markers (Stra 8, Scp3 and Dmc1) using Dream
Taq DNA polymerase (Fermentas Life Sciences; Vil-
nius, Lithuania). Briefly, the cDNA mix (2 μl) was amp-
lified using 0.2mM of each primer (Table 3), 1.25 unit
of DreamTaq DNA polymerase (Fermentas) in 1x
Dream Taq buffer (Fermentas) and 0.2mM dNTPs in a
G-STORM thermocycler. Amplification was carried
out for 35 cycles, with each cycle consisting of de-
naturation at 94°C for 30 sec, annealing at the specified
temperature (Table 3) for 20 sec, and extension at 72°C
for 30 sec. The products were analyzed on 2% agarose
gel stained with 0.5 μg/ml ethidium bromide (Banga-
lore Genei, Bangalore, India). The product size was
approximated using a 100-bp DNA ladder (Bangalore
Genei). The negative control did not include cDNA in
the reaction mixture. Normal adult mouse testis was
used as positive control.
Quantitative PCR
Q-PCR was carried out to study the expression of vari-
ous gene transcripts mentioned in Table 3. The expres-
sion levels of these gene transcripts in relation to
housekeeping gene transcript 18s were estimated by
CFX96 Real-time PCR system (Bio-Rad Laboratories,
Hercules, CA) using SYBR Green chemistry (Bio-Rad).
The primers and their respective annealing temperatures
used in the study are mentioned in Table 3. All the primershad efficiency close to 100% and all primers except Gapdh
and Nanog are exon-exon spanning primers. The amplifica-
tion conditions included initial denaturation at 94°C for 3
min followed by 40 cycles comprising of denaturation at
94°C for 30 secs, primer annealing for 20 secs and exten-
sion at 72°C for 30 secs. The final step included incubation
at 94°C for 20 secs to remove any secondary structures fol-
lowed by melt curve analysis. The fluorescence emitted at
each cycle was collected during the extension step of each
cycle. The homogeneity of the PCR amplicons was verified
by running the products on 2% agarose gels and also by
studying the melt curve. All PCR amplifications were car-
ried out in duplicate. Mean Ct values generated in each ex-
periment using the CFX Manager software (Bio-Rad) were
used to calculate the mRNA expression levels. Since ΔCt is
inversely proportional to relative mRNA expression levels,
the levels were calculated manually by the ΔCt method.
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Histological studies
Ovarian surface epithelium (OSE) during different stages of
estrus cycle
Majority of epithelium covering the ovarian surface dur-
ing different stages of the estrus cycle comprised of cu-
boidal or flat epithelial cells (Figure 1 & 2). In
comparison to diestrus stage (Figure 1 A & B) where
OSE was cuboidal to flat, small regions of OSE appeared
prominent and highly folded, gave multilayered appear-
ance in proestrus and estrus stages (Figure 1C & D, Fig-
ure 2 respectively). Cohorts of PFs were invariably
visualized under this region of OSE, especially during
the estrus stage. At places, relatively large cells with pale
cytoplasm, surrounded by a single layer of somatic
granulosa-like cells were observed in the OSE (Figure 2
C-F). The cohorts of PFs appeared to have cytoplasmic
continuity at places (Figure 2 D & F). It appeared as if
PF undergo follicular assembly in the OSE and then get
pinched off from the OSE and shift to the cortex region
just below the OSE always in a cohort.
Ovarian surface epithelium after two (2D) and seven (7D)
days post PMSG treatment
PMSG had a profound effect on OSE in addition to its
known effect on growing cohort of follicles. 2D after
PMSG treatment, OSE exhibited extensive proliferation
in agreement with earlier reports [29-31]. We also
observed OSE having multilayered appearance alongFigure 1 Whole ovary histo-architecture during different stages of es
of development and corpus lutea can be observed. A & B During di-estrus
cells. C & D During pro-estrus stage, a small area of the surface epithelial c
Bar: A&C-100μm, B&D-20μm.with the presence of small outgrowths, which enclosed
many PFs (Figure 3). Increased vascularity near the OSE
was also observed. The ovaries from 7D PMSG treated
mice showed striking difference when compared at lower
magnification to ovary from control (Figure 4 & 5). As
evident, in control ovarian section during the estrus
phase, only a single small region of OSE showed prolif-
eration, had multilayer appearance and a cohort of PF
was observed (Figure 4A). In contrast, the OSE after 7D
of PMSG revealed the presence of 5–8 regions where
the OSE was of hyper proliferative nature accompanied
with the presence of several cohorts of PF (Figure 4B,
Figure 5A & B). However, in comparison to 2D, the pro-
tuberances in OSE were reduced on 7D. At places,
PF assembly was evident in OSE (Figure 5 & 6) wherein
a large germ cell with abundant pale cytoplasm
was observed in the OSE. Nests of follicles were also
observed with prominent ooplasm continuity. It
appeared that after PF assembly, these PF were pinched
off and shifted to the ovarian cortex just below the OSE,
similar to control ovaries in the estrus phase (Figure 2).
However, PMSG exposure accelerated the frequency of
the whole process of oogenesis and PF assembly.
Immunolocalization studies
FSH receptors
FSHR immunolocalization was relatively less in control
ovarian sections (Figure 7A & B). Minimal staining was
observed in OSE, oocytes and corpus luteal cells whereastrus cycle in one month old Swiss mice. Follicles in different stages
stage, the ovarian surface is covered with cuboidal or flat epithelial
rypt reveals the presence of columnar epithelial cells (arrowhead).
Figure 2 Whole ovary histo-architecture during estrus stage of the cycle in one month old Swiss mice. A Small area of OSE shows the
presence of columnar epithelial cells giving highly folded multi-layered appearance (box). B Under higher magnification a cohort of primordial
follicles (PF) are observed in the area where OSE exhibits proliferation. C-F The PF have cytoplasmic connections (arrow) between them. At places
one can observe PF just below the OSE. PF assembly is evident in the OSE (circle). Bar: A-100μm, B-F-20μm.
Figure 3 Ovary histo-architecture after two days of PMSG treatment. As compared to estrus stage, two days of PMSG treatment results in
increased proliferation of OSE at several places (arrowhead). A large number of mature, unruptured follicles are observed and corpus lutea are
absent. There is slight increase in vascularization just below the OSE. The small protuberances on the ovarian surface are marked by epithelial
cells present in multi-layer and have several PF within them. Bar: A-100μm, B-E-20μm.
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Figure 4 A comparative histo-architecture of mouse ovary during normal estrus stage and 7 days after PMSG treatment. As evident,
focal areas where OSE gives multilayer appearance and has associated cohort of PF are markedly increased after PMSG treatment B (arrow head)
as compared to control A Bar: 100μm.
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losa cells of mature follicles (Figure 7B). The oocyte also
showed positive immunostaining for FSHR (Figure 7A
& B). PMSG treatment had a profound effect on FSHR
expression pattern in the ovarian sections (Figure 7C-D).
An increased staining was observed in granulosa cells,
OSE cells (Figure 6C) and oocytes of primordial, primaryFigure 5 Ovarian histo-architecture after 7 days of PMSG treatment. A
multilayered OSE and associated cohorts of PF. C & D Higher magnification
evident (arrowhead). Bar: A&B-100μm, C&D-20μm.and secondary follicles. The granulosa cells in primordial
follicle were distinctly negative for FSHR.PCNA
As compared to control (Figure 8A), PMSG treated OSE
(Figure 8B & C) showed increased PCNA staining. The& B Whole ovary sections showing several focal areas with
of the region with multilayer OSE and PF. PF assembly in the OSE is
Figure 6 Higher magnification of D7 PMSG treated H & E stained ovarian sections. The epithelial cells appear proliferative and multilayered.
A cohort of PF is invariably observed below such regions of OSE. Note increased vascularity in this region (star) and cytoplasmic connection
between the oocytes of two adjacent PF (arrows). The PF assembly occurs in the OSE (arrowhead). The oocytes are large in size with abundant
pale cytoplasm whereas granulosa cells have more fibroblast-like appearance and are observed surrounding the oocytes. Bar: 20μm.
Figure 7 Follicle stimulating hormone receptor (FSHR) immunolocalization in estrus stage and after 7D of PMSG treatment. A & B In
control, minimal staining is observed in the OSE cells. However, distinct immunolocalization is observed in the oocyte of the PF (black arrow),
whereas the surrounding granulosa cells are negative. The granulosa cells in large follicles show positive staining (blue arrow). Positive staining is
also observed in the oocyte in large follicle (asterisk). C & D Increased immunostaining pattern is observed after PMSG treatment in the
multilayered OSE, oocytes of primordial and developing primary to secondary follicles. Inserts show follicles in various developmental stages with
granulosa cells negative for FSHR. Note change in shape of the granulosa cells from flat to cuboidal as the PF transits into a primary follicle.
Bar=20μm.
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ent staining suggesting the PFs were newly assembled
(Figure 8B’). PCNA labeling was also observed in the
granulosa cells of developing follicles. As expected, the
oocytes of bigger follicles were negative for PCNA (data
not shown).
OCT-4
In control samples, faint OCT-4 staining was observed
in the ooplasm of primordial follicles (Figure 8D). In 7D
PMSG treated ovarian sections, OCT-4 staining was
more intense and the PFs lying below the OSE showed
both nuclear (arrowhead) and cytoplasmic staining for
OCT-4. However, the surrounding granulosa cells were
distinctly negative for OCT-4 (Figure 8 E & F) in both
control and after PMSG treatment.
MVH
MVH (a proliferating germ cell and oocyte marker) was
localized in the ooplasm of primordial to secondary fol-
licular oocytes (Figure 8G). Some of the primordial folli-
cles in cohorts still appeared cytoplasmically connected
without any intervening granulosa cell (Figure 8G’, arrow-
head) and exhibited positive MVH staining. Also at
places cluster of germ cells in the OSE also stainedFigure 8 Immuno-staining on control and PMSG treated ovarian secti
PCNA staining in control OSE. Increased staining is observed after PMSG tre
magnified image of the PF located in the OSE. At places, granulosa cells w
anti-OCT-4 antibody in control (D) and 7D PMSG treated (E&F) ovarian sect
treated, positive staining was observed in ooplasm as well as in the nucleu
anti-human VASA antibody that cross-reacts with mouse MVH. MVH is disti
a ‘germ cell nest’ (G’, arrow). At places some oocytes of primordial follicles
(arrowhead) H-J: SCP-3 is localized in PF oocytes present in close vicinity opositive for MVH (Figure 8G’, arrow), probably represent-
ing mitotically dividing pre-meiotic germ cell nests,
which are well documented in perinatal mouse ovary
[60].
SCP3
SCP3, a meiotic marker was distinctly immuno-localized
in the nuclei of some oocytes along OSE after PMSG
treatment. The staining of SCP3 was evenly localized
throughout the nuclei in 7D post PMSG (Figure 8 H-J)
suggesting oocytes in meiosis prophase I. Nucleolar stain-
ing was occasionally observed in primordial follicles of
control as well as in 2D post treatment (data not shown).
Gene transcript analysis
RT-PCR
Figure 9 shows RT-PCR results for pre-meiotic and mei-
otic markers using normal adult testicular tissue as posi-
tive control. Only few of the samples namely control C2,
2D2 and 7D1 of PMSG treated samples showed faint
positivity for Stra8 when compared to brightly positive
band from control testicular samples. This may be be-
cause very few cells in whole ovary undergo meiosis and
normally STRA8 positive cells are rarely detected in
young adults [61]. Niikura et al. [61] suggested that thisons. A-C: Immunostaining with anti-PCNA antibody. Note minimal
atment in both the OSE cells and the oocytes of PF (B-&C). Inset B’ is
ere also positive for PCNA (arrowhead). D-F: Immunostaining with
ions. OCT-4 is localized in the ooplasm in control, while in 7D PMSD
s of few oocytes (arrowhead) in PFs. G: Immunostaining with
nctly localized in the ooplasm of PF and at places was also observed in
in cohorts appeared connected without intervening granulosa cell
f multilayer OSE. Bar: 20μm.
Figure 9 RT-PCR results for pre-meiotic (Stra8) and meiotic (Scp3, Dmc-1) markers in control and PMSG treated ovaries along with
testis as positive control. Note Stra8 is observed only in control sample C2, 2D PMSG sample 2D2 and 7D PMSG sample 7D2 at very low levels
compared to testicular sample. Meiotic marker Scp3 and Dmc1 are upregulated in PMSG treated samples. Each sample was obtained by pooling
ovaries from two animals.
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once committed by inducing Stra8 expression, into
oocytes during young adulthood. On the other hand,
meiotic markers Scp3 and Dmc1 were detected in all the
samples studied, albeit at very low levels in control sam-
ples. This suggests meiosis occurrence at extremely low
level in normal adult ovary, while it is upregulated dur-
ing PMSG treatment. To further confirm this, Q-PCR
analysis of Scp3 was performed.Q-PCR analysis of various transcripts
The Q-PCR data obtained by analysis of control and PMSG
treated ovaries is presented (Figure 10). As expected, a sig-
nificant increase in Fshr mRNA expression was noted on
2D after PMSG treatment compared to control sample and
showed slight reduction by 7D. PMSG treatment also led to
increased stem cell activity as evident by increase in expres-
sion of stem cell and primordial germ cell markers includ-
ing Oct-4A, Nanog, total Oct-4, Fragilis and Stella on D2
after PMSG and were further increased or sustained by D7.
As mentioned earlier, we have previously reported that the
pluripotent VSELs have nuclear OCT-4 (specific transcript
is Oct-4A) and once they initiate differentiation, OCT-4
shifts to cytoplasm in OGSCs [32]. Results of the present
study indicate that the increase in total Oct-4 post PMSG
treatment was more than the increase in Oct-4A (Fig-
ure 10), suggesting that OGSCs are also proliferating post-
PMSG treatment. Also increase in expression was observed
in germ cell marker (Mvh) and interestingly significant in-
crease in Nobox was maximally observed on 7D. HoxA10
was decreased on 2D post treatment probably because of
maturation of pre-existing primordial and primary follicles.
Interestingly, the HoxA10 levels increased on 7D and
reached levels comparable to control suggesting formation
of new primordial follicles post PMSG treatment. RT-PCR
and Q-PCR analysis for the meiotic marker Scp3 alsoshowed a significant increase 7D after PMSG treatment
suggesting increase in meiosis post treatment.
Discussion
Present study demonstrates that pluripotent stem cells
VSELs and progenitors OGSCs reported earlier by our
group in adult mice, rabbit, sheep, monkey and human
ovary [32,39] are possibly regulated by FSH and are respon-
sible for postnatal oogenesis and follicular assembly during
adult reproductive life. Normal adult mice ovaries were
studied during different stages of estrus cycle and after 2
and 7 days of PMSG treatment by histology, immunolocali-
zation (FSHR, PCNA, OCT-4, SCP3 and MVH), and RT-
PCR/ Q-PCR for various gene transcripts including pluri-
potent (Oct-4A, Nanog); early germ cell (total Oct-4, Stella,
Fragilis, Mvh), oocyte-specific (Nobox & HoxA10); pre-
meiosis (Stra8) and meiosis (Scp3, Dmc1) specific markers.
The process of ovarian stem cell differentiation and meiosis
giving rise to new oocytes, which get enclosed by the gran-
ulosa cells to assemble as PFs in the OSE appears to be a
normal feature of adult ovary (Figure 1,2). The granulosa
cells arise by epithelial-mesenchymal transition of OSE as
suggested earlier by us based on in vitro evidence [32].
Present study provides in vivo evidence in favor of our earl-
ier observations that OSE cells may be involved in the for-
mation of granulosa cells (Figure 6B,C, E & F). PMSG
treatment further augments the process of postnatal oogen-
esis and PF assembly resulting in increased PFs by D7 (Fig-
ure 3, 4, 5, 6).
PMSG is known to exert its actions on mammalian ovary
through FSH-FSHR interaction. In the present study, be-
sides granulosa cells of bigger follicles, FSHR was detected
in both OSE and oocytes of PF in agreement with earlier
reports [15-17,19,27,28] and an up-regulation was
observed after PMSG treatment at both protein by immu-
nohistochemistry (Figure 7) and transcript (Figure 10)
level. Presence of FSHR in locations like oocytes and OSE
Figure 10 Q-PCR analysis of various gene transcripts in ovaries from control, 2D and 7D after PMSG treated mice. Note an increase in
Fshr mRNA expression after PMSG treatment on D2, which slightly reduced by 7D of PMSG treatment. All other markers specific for pluripotent
stem cells, germ cells, oocytes and meiosis showed an increase in mRNA expression after PMSG treatment to varying degree except for HoxA10.
Increase in pluripotent (Oct-4A and Nanog) and meiotic marker (Scp3) after PMSG treatment suggest that the VSELs get stimulated by PMSG
treatment, undergo further proliferation, differentiation and meiosis leading to neo-oogenesis and PF assembly. Each sample was obtained by
pooling ovaries from two animals.
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probably not exerted only through the classical FSHR
present on the granulosa cells of growing follicles. Sairam’s
group has earlier reported that FSH may exert diverse
actions through alternatively spliced FSHR isoforms based
on their studies from sheep and mice ovaries [62-64].
In the current study, upregulation of FSHR after PMSG
treatment correlated well to the proliferation observed in
OSE. OSE proliferation and multilayer appearance which
were normally observed in control ovaries at few focal
areas were increased after PMSG treatment (Figure 3 & 4).
Ovarian sections on 2D of PMSG treatment showed the
presence hyperplastic epithelial cells and small protuber-
ances bulging from the ovarian surface (Figure 3) which
subside by 7D (Figure 4, 5, 6). PF cohorts normally
observed with hyper-proliferative OSE regions in control
ovaries, increased significantly after 7D of PMSG treatment
in the ovarian cortex (Figure 4 & 5). This correlated well
with increased mRNA expression for HoxA10- a primor-
dial follicular oocyte marker [58] and Nobox that isexpressed abundantly in primordial and primary follicular
oocytes [58] post PMSG treatment. Occurrence of meiosis
was supported by expression of pre-meiotic (Stra8) and
meiotic (Scp3 and Dmc 1) markers. All the three markers
were detected in control as well as all PMSG treated ovar-
ian samples. A distinct up regulation of Scp3 was noted
after PMSG treatment, both at the protein (Figure 8 H-
J) and mRNA transcript level (Figure 9 &10). As
reported earlier [65], SCP3 staining was observed through-
out the nuclei suggesting that the oocytes are in prophase I
of meiosis and was gradually lost in more developed
oocytes. The PF at birth are generally arrested in diplotene
stage of prophase 1 of meiosis. SCP3 expression is
restricted to earlier stages i.e. zygotene and pachytene
stage. Thus expression of Scp3 and pre-meiotic marker
Stra8 in adult ovary are considered direct evidence in sup-
port of postnatal oogenesis and have been reported earlier
by other groups also [36,66].
It is intriguing to point out that OSE which expresses
FSHR also lodges VSELs as observed in rabbit, sheep,
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VSELs with nuclear OCT-4 differentiate into ‘progeni-
tors’ ovarian germ stem cells (OGSCs) with cytoplasmic
OCT-4 and undergo spontaneous differentiation into
oocyte-like structures in vitro [32,37]. Possibly, in the
present study, the pluripotent VSELs were activated by
PMSG treatment (increased expression of Oct-4A,
Nanog Figure 8 & 10), undergo proliferation (increased
PCNA staining and Oct-4A expression, Figure 8) and
differentiation (increased expression of stella, fragilis,
total Oct-4, Vasa and MVH Figure 8 & 10) resulting in
meiosis (Stra-8, Scp3 and Dmc1 Figure 8, 9, 10) and for-
mation of oocyte nests with prominent intercellular
cytoplasmic bridges that assemble to form PF in the
OSE (Figure 2 & 6). These nests later shift to the cortex
and are visualized as small cohorts on 7D after PMSG
treatment. This data demonstrates the mechanism of oo-
genesis occurring in situ in adult ovary for the first time
in OSE similar to well-studied spermatogenesis in the
testicular seminiferous tubules where the VSELs are
lodged at the basement membrane [67,68]. The process
is regulated by FSH and is in contradiction to the exist-
ing paradigm that initial PF growth is gonadotropin in-
dependent [69,70]. The results of the present study
support the model for postnatal oogenesis proposed by
us earlier [39].
Messinis et al. [70] have reviewed a huge body of lit-
erature and summarized the current understanding of
the role played by FSH during folliculogenesis. Accord-
ing to existing understanding, the ‘intercycle peak’ of
FSH is crucial and responsible for ‘cyclic recruitment’ of
follicles. Ovary experiences waves of folliculogenesis and
a cohort of follicles start growing in each cycle, however,
only one becomes dominant and others undergo atresia
[69]. On treating with gonadotropins, FSH window gets
widened and multiple follicles get selected and start to
grow. Whether more follicles get recruited due to the
treatment or FSH prevents atresia in the already
recruited cohort of PF is still controversial. Results of
the present study add another dimension to this by dem-
onstrating that FSH also exerts action on the OSE and
induces neo-oogenesis and PF assembly from the stem
cells residing in the OSE.
The prevailing notion of extrusion of atretic oocytes
from the ovary surface [71-73] or that the PF may get
pushed to the ovarian surface because of the growing
follicles in response to the PMSG treatment (and thus
increased number of PF are visualized after treatment in
the present study) may not be valid since this reasoning
cannot account for distinct increased pattern of pluri-
potent and meiotic markers in the developing follicles
(Figure 7, 8, 9) observed in the present study. Also the
earlier published reports of BrdU incorporation in OSE
[34,36] may not be due to mtDNA synthesis – rather itmay be due to stem cell activity that gets augmented
by PMSG.
The extensive germ cell nest formation, initiation of
meiosis, PF assembly etc. are well documented and stud-
ied during fetal ovarian development in the existing lit-
erature [60]. It is interesting to point out that the stage
of fetal development when PF assembly occurs is actu-
ally associated with several folds higher levels of FSH in
females [2-6,74]. Thus FSH is directly related to PF as-
sembly and regular intercycle peak of FSH may be
stimulating the VSELs to result in differentiation and PF
assembly. Lei et al. [74] reported that the high levels of
circulatory FSH in perinatal period and increased FSHR
mRNA in mouse ovaries facilitate germline nest break-
down and PF assembly.
Conclusions
We propose that PMSG treatment through induction of
FSH-FSHR action possibly stimulates the pluripotent
VSELs residing in the OSE leading to proliferation and
differentiation of OGSCs to oocytes and primordial fol-
licle assembly. These results are in contradiction to the
existing paradigm that ovaries have fixed number of fol-
licles in adulthood and that early PF growth is independ-
ent of FSH.
The results of the present study are in direct agreement
with postnatal oogenesis proposed by Tilly’s group in 2004
[36]. We propose that intercycle FSH peak is probably
associated with cyclic recruitment of VSELs in the OSE
throughout reproductive life and results in neo-oogenesis
and PF assembly. Several fold elevated FSH levels in fe-
male fetus during peri-natal period [2-6] are possibly re-
sponsible for increased PF assembly well documented
during fetal development. Moreover, since VSELs exist in
various body organs, it would be interesting to study
whether only ovarian VSELs are selectively stimulated by
FSH or even VSELs in testis [67,68] or bone marrow [75]
etc. are also regulated by FSH. It is indeed intriguing that
despite exploiting the ovaries for so many years as a
source of eggs, present study has provided newer informa-
tion towards the mechanism of action of FSH on the ovar-
ies. Elevated FSHR3 (an isoform of FSHR) in OSE has
been implicated in ovarian cancers [25]. It is highly likely
that the VSELs residing in the OSE may also be implicated
in the ovarian cancers as has been proposed earlier [76,77].
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